April 4, 2022 – Staying well-hydrated may be associated with a reduced risk for developing heart failure, according to ...
Diagnostic and Interventional Cardiology DAIC
Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.
April 4, 2022 – Observational research has suggested that light alcohol consumption may provide heart-related health ...
April 4, 2022 – Deep in the brain a group of large neurons produce a hormone which prompts our bodies to hold onto more ...
April 4, 2022 – Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart ...
April 4, 2022 – Esperion presented two new analyses from its clinical development program of bempedoic acid (NEXLETOL) ...
April 3, 2022 — egnite, Inc., an advanced technology digital health company focused on providing artificial intelligence ...
April 3, 2022 — A new drug shows promise in providing relief to cardiomyopathy patients experiencing shortness of breath ...
April 3, 2022 — Silence Therapeutics, a leader in the discovery, development and delivery of novel short interfering ...
April 1, 2022 — A new joint guideline published today from the American College of Cardiology, the American Heart ...
April 1, 2022 – The activation of the bone marrow appears to play a key role in the origin and development of ...
April 1, 2022 — Royal Philips, a global leader in health technology, announced new additions to its innovative ...
Here is what you and your colleagues found to be most interesting in the field of cardiology during the month of March ...
March 31, 2022 — The annual congress of the European Heart Rhythm Association (EHRA), a branch of the ESC, will be held ...
March 31, 2022 – Windtree Therapeutics, a biotechnology company focused on advancing multiple late-stage interventions ...
March 31, 2022 – Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral ...
April 04, 2022